Form 4 Regulus Therapeutics For: Jul 23 Filed by: ALNYLAM PHARMACEUTICALS, INC.
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140725/ANZ8J22C3Z22K2GZ2S982CZ2P63RZ22RZ262
Filed on: July 25, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Graid Technology Announces Software Update, Delivers Enhanced Levels of Data Integrity and Business Continuity
- Life Science Analytics Market Projected to Reach USD 18.96 billion by 2031
- Hobas Pipe USA, Inc. Expands Production to Meet Growing Infrastructure Demand
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
